tdk5005
tdk5005
Sex: M
Data Quality: 2 stars
MS: 8 yrs
Type: Relapsing-Remitting
Sensation: Mild
Overall: None
Cognition: none
Vision: none
Speech: none
Swallowing: none
Upper limb: none
Walking: none
tdk5005
Male, 26 years
Paoli, PA
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
11/03
Diagnosis
06/04
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

tdk5005's Glatiramer acetate is for:

  • MS

tdk5005's side effects of Glatiramer acetate:

tdk5005's Glatiramer acetate History (Ongoing)
20 mg Daily May 01, 2007 - Last Update
Evaluations
Date Dosage MS (Multiple Sclerosis) Efficacy Side Effects Adherence Burden
Dec 08, 2008 20 mg Daily ? MildMildMildMild AlwaysAlwaysAlwaysAlways A littleA littleA littleA little

About Glatiramer acetate (Prescription Drug)

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Learn more about Glatiramer acetate in our Glatiramer acetate Community Report.